Sort
48,018 grants matching “immunotherapy”
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
$368,249Scott I. Abrams · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Antigenic determinants on HLA-B7 and-A2
$368,221University Of Virginia Charlottesville · R01 · FY2002 · AI
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
$368,191Michael B Lilly · Medical University Of South Carolina · K12 · FY2014 · CA
Memory CD8 T Cell Responses After Multiple Antigen Encounters
$368,191Vladimir P Badovinac · University Of Iowa · R01 · FY2010 · AI
Antigenic determinants on HLA-B7 and-A2
$368,168University Of Virginia Charlottesville · R01 · FY2003 · AI
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$368,165Laurie E Littlepage · University Of Notre Dame · R01 · FY2024 · CA
Imaging T-cell Activation and Co-stimulation in Prostate Cancer Immunotherapy
$368,132Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Antigenic determinants on HLA-B7 and-A2
$368,113University Of Virginia Charlottesville · R01 · FY2004 · AI
Optimizing CAR T Cell Therapy
$368,110Bruce R. Blazar · University Of Minnesota · P01 · FY2019 · CA
Clinical Fellowship Training Program
$368,094Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2011 · CA
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
$368,058Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
Antigenic determinants on HLA-B7 and-A2
$368,056University Of Virginia Charlottesville · R01 · FY2005 · AI
CAR T platform to treat solid tumors
$368,052Joana M Murad · Celdara Medical, Llc · R43 · FY2022 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$368,044Andrew E Aplin · Wistar Institute · P01 · FY2022 · CA
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$368,038Rebekah White · University Of California, San Diego · R01 · FY2024 · CA
Immunotherapy for Skin Cancer Precursors to Prevent Skin Cancer
$368,018Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2019 · AR
LIGHT co-stimulatory therapy on GVHD and GVL
$368,010Koji Tamada · Johns Hopkins University · R01 · FY2007 · HL
Immunomodulation in melanoma therapy
$368,000Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2009 · CA
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
$367,998Paul Nghiem · University Of Washington · P01 · FY2023 · CA
Design of de novo interleukin mimics for targeted immunotherapy
$367,987David Baker · University Of Washington · R01 · FY2022 · CA
Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer
$367,975Kamiya Mehla · University Of Oklahoma Hlth Sciences Ctr · R37 · FY2024 · CA
Virulence and Immunity to Staphylcocci
$367,971Brigham And Women'S Hospital · R01 · FY2001 · AI
Harnessing Alloreactivity
$367,940Fuchs Ephraim · Johns Hopkins University · P01 · FY2011 · CA
Understanding Immunopathogenesis of Hepatitis B Virus
$367,923Jody L Baron · University Of California, San Francisco · R01 · FY2009 · AI
Project 2
$367,909Felicity Harper · Wayne State University · P20 · FY2022 · CA